COMMUNIQUÉS West-GlobeNewswire

Eidos Therapeutics to Host Conference Call and Webcast to Discuss ATTR-CM Phase 3 Trial (ATTRibute-CM) Design

25/02/2019 - 14:00

SAN FRANCISCO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need caused by transthyretin [...]

CRISPR Therapeutics and Vertex Announce Progress in Clinical Development Programs for the Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001

25/02/2019 - 14:00

-First patient infused with CTX001 in a Phase 1/2 clinical trial for patients with beta thalassemia- - First patient enrolled in a Phase 1/2 clinical trial of CTX001 for patients with sickle cell disease- ZUG, [...]

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 18, 2019

25/02/2019 - 14:00

CANTON, Mass., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]

NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research

25/02/2019 - 14:00

55.2% improvement in baseline pain scores versus 2.3% for the control group 46.4% reduction in breakthrough pain medication, including opioids, versus 1.5% versus for the treatment group PainShield™ had no adverse [...]

CEO of TRHC’s New Research & Development Institute to Present at National University of Singapore

25/02/2019 - 14:00

MOORESTOWN, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that TRHC’s Chief [...]

Inovalon to Present at Morgan Stanley Technology, Media & Telecom Conference

25/02/2019 - 13:55

BOWIE, Md., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D [...]

Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5

25/02/2019 - 13:50

BOSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that management will host a conference call and webcast slide presentation on Tuesday, March 5, at 4:30 p.m. ET to provide [...]

Blueberries Medical Enters into Agreement with a Leading Colombian Craft Brewer to Pioneer the Development and Commercialization of Cannabis Based Beverages in Latin America

25/02/2019 - 13:45

TORONTO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “ Company ” or " Blueberries ") a leading Colombia-based licensed producer of medicinal cannabis and cannabis-derived products, [...]

ADMA Biologics to Present at Upcoming Investor Conferences

25/02/2019 - 13:38

Raymond James 40 th Annual Institutional Investors Conference Oppenheimer’s 29 th Annual Healthcare Conference RAMSEY, N.J. and BOCA RATON, Fla., Feb. 25, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ [...]

REVA Announces Extension to Voluntary Suspension of Trading

25/02/2019 - 00:32

SAN DIEGO, Feb. 24, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 25 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]

Philips showcases unique augmented reality concept for image-guided minimally invasive therapies developed with Microsoft

24/02/2019 - 18:45

February 24, 2019 Companies collaborate to combine Philips’ industry-leading Azurion image-guided therapy platform with Microsoft HoloLens 2 mixed reality computing platform as a concept for the operating room of the [...]

BioCryst Reports ZENITH-1 Results With Oral BCX7353 Which Confirm Rapid Onset of Action, Sustained Activity and Robust Dose Response for Treatment of Acute HAE Attacks

23/02/2019 - 18:45

— Based on ZENITH-1 data, company plans to commence Phase 3 trial of single-dose 750 mg oral BCX7353 for acute treatment of hereditary angioedema (HAE) attacks in summer 2019— —Data show excellent clinical dose response [...]

FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results

23/02/2019 - 05:43

SAN FRANCISCO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced that it will [...]

SHDS Informs Individuals of Security Incident Affecting Subset of Patients of East Los Angeles Doctors Hospital and Other Customers

23/02/2019 - 00:02

SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Sharecare Health Data Services (“SHDS”), formerly known as BACTES Imaging Solutions, announced today that some personal information, including protected health information, [...]

Fluidigm to Participate in Upcoming Investor Conferences

22/02/2019 - 23:30

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced [...]

Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

22/02/2019 - 22:16

BOTHELL, Wash., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

OrthoPediatrics Corp. Honored as One of the Best Place to Work in Indiana for a Third Year

22/02/2019 - 22:05

WARSAW, Ind., Feb. 22, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that it was recently named as [...]

priMED Medical Products Named 2019 Alberta’s Top Employer

22/02/2019 - 21:08

Corporate culture, working environment, employee health, and social responsibility cited as key factors in winning the award EDMONTON, Alberta, Feb. 22, 2019 (GLOBE NEWSWIRE) -- After a banner year in 2018, priMED [...]

Canaccord Genuity initiates research coverage of CLS Holdings

22/02/2019 - 20:28

LAS VEGAS, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Canaccord Genuity, the largest independent investment dealer in Canada, has initiated research coverage of CLS Holdings USA Inc. (OTCQB:CLSH). The initiation report is 38 [...]